Formation of Neu/ErbB2-induced mammary tumors is unaffected by loss of ErbB4

A. J. Jackson-Fisher, G. Bellinger, E. Shum, J. K. Duong, A. S. Perkins, M. Gassmann, W. Muller, Kevin C K Lloyd, D. F. Stern

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The four members of the ErbB family of receptor tyrosine kinases are involved in development and tumorigenesis of the mammary gland. Whereas the epidermal growth factor receptor, ErbB2 and ErbB3 are positively associated with various cancers, clinical studies of ErbB4 in breast cancer are contradictory. Results from tissue culture analyses and some clinical studies suggested that ErbB4 is either a tumor suppressor or is a negative regulator of ErbB2-driven tumors. Neu-Cre-ErbB4flox/null mice in which ErbB4 was inactivated by Cre-lox-mediated recombination in the mammary gland developed MMTV-Neu-driven mammary tumors with a similar latency period to mice with one or two wild-type ErbB4 alleles. Moreover, there was no difference in the histologies of tumors that developed, nor in the propensity to form lung metastases. Taken together these results suggest that ErbB4 is not a potent, highly penetrant tumor suppressor, nor is it a factor in Neu-mediated tumorigenesis in this model.

Original languageEnglish (US)
Pages (from-to)5664-5672
Number of pages9
JournalOncogene
Volume25
Issue number41
DOIs
StatePublished - Sep 14 2006

Fingerprint

Breast Neoplasms
Human Mammary Glands
Neoplasms
Carcinogenesis
Epidermal Growth Factor Receptor
Protein-Tyrosine Kinases
Genetic Recombination
Histology
Alleles
Neoplasm Metastasis
Lung
Clinical Studies

Keywords

  • Breast cancer
  • Carcinoma
  • ErbB
  • HER-4
  • MMTV-Neu

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Jackson-Fisher, A. J., Bellinger, G., Shum, E., Duong, J. K., Perkins, A. S., Gassmann, M., ... Stern, D. F. (2006). Formation of Neu/ErbB2-induced mammary tumors is unaffected by loss of ErbB4. Oncogene, 25(41), 5664-5672. https://doi.org/10.1038/sj.onc.1209574

Formation of Neu/ErbB2-induced mammary tumors is unaffected by loss of ErbB4. / Jackson-Fisher, A. J.; Bellinger, G.; Shum, E.; Duong, J. K.; Perkins, A. S.; Gassmann, M.; Muller, W.; Lloyd, Kevin C K; Stern, D. F.

In: Oncogene, Vol. 25, No. 41, 14.09.2006, p. 5664-5672.

Research output: Contribution to journalArticle

Jackson-Fisher, AJ, Bellinger, G, Shum, E, Duong, JK, Perkins, AS, Gassmann, M, Muller, W, Lloyd, KCK & Stern, DF 2006, 'Formation of Neu/ErbB2-induced mammary tumors is unaffected by loss of ErbB4', Oncogene, vol. 25, no. 41, pp. 5664-5672. https://doi.org/10.1038/sj.onc.1209574
Jackson-Fisher AJ, Bellinger G, Shum E, Duong JK, Perkins AS, Gassmann M et al. Formation of Neu/ErbB2-induced mammary tumors is unaffected by loss of ErbB4. Oncogene. 2006 Sep 14;25(41):5664-5672. https://doi.org/10.1038/sj.onc.1209574
Jackson-Fisher, A. J. ; Bellinger, G. ; Shum, E. ; Duong, J. K. ; Perkins, A. S. ; Gassmann, M. ; Muller, W. ; Lloyd, Kevin C K ; Stern, D. F. / Formation of Neu/ErbB2-induced mammary tumors is unaffected by loss of ErbB4. In: Oncogene. 2006 ; Vol. 25, No. 41. pp. 5664-5672.
@article{bb4462308b3d4385b52fcafcb292228c,
title = "Formation of Neu/ErbB2-induced mammary tumors is unaffected by loss of ErbB4",
abstract = "The four members of the ErbB family of receptor tyrosine kinases are involved in development and tumorigenesis of the mammary gland. Whereas the epidermal growth factor receptor, ErbB2 and ErbB3 are positively associated with various cancers, clinical studies of ErbB4 in breast cancer are contradictory. Results from tissue culture analyses and some clinical studies suggested that ErbB4 is either a tumor suppressor or is a negative regulator of ErbB2-driven tumors. Neu-Cre-ErbB4flox/null mice in which ErbB4 was inactivated by Cre-lox-mediated recombination in the mammary gland developed MMTV-Neu-driven mammary tumors with a similar latency period to mice with one or two wild-type ErbB4 alleles. Moreover, there was no difference in the histologies of tumors that developed, nor in the propensity to form lung metastases. Taken together these results suggest that ErbB4 is not a potent, highly penetrant tumor suppressor, nor is it a factor in Neu-mediated tumorigenesis in this model.",
keywords = "Breast cancer, Carcinoma, ErbB, HER-4, MMTV-Neu",
author = "Jackson-Fisher, {A. J.} and G. Bellinger and E. Shum and Duong, {J. K.} and Perkins, {A. S.} and M. Gassmann and W. Muller and Lloyd, {Kevin C K} and Stern, {D. F.}",
year = "2006",
month = "9",
day = "14",
doi = "10.1038/sj.onc.1209574",
language = "English (US)",
volume = "25",
pages = "5664--5672",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "41",

}

TY - JOUR

T1 - Formation of Neu/ErbB2-induced mammary tumors is unaffected by loss of ErbB4

AU - Jackson-Fisher, A. J.

AU - Bellinger, G.

AU - Shum, E.

AU - Duong, J. K.

AU - Perkins, A. S.

AU - Gassmann, M.

AU - Muller, W.

AU - Lloyd, Kevin C K

AU - Stern, D. F.

PY - 2006/9/14

Y1 - 2006/9/14

N2 - The four members of the ErbB family of receptor tyrosine kinases are involved in development and tumorigenesis of the mammary gland. Whereas the epidermal growth factor receptor, ErbB2 and ErbB3 are positively associated with various cancers, clinical studies of ErbB4 in breast cancer are contradictory. Results from tissue culture analyses and some clinical studies suggested that ErbB4 is either a tumor suppressor or is a negative regulator of ErbB2-driven tumors. Neu-Cre-ErbB4flox/null mice in which ErbB4 was inactivated by Cre-lox-mediated recombination in the mammary gland developed MMTV-Neu-driven mammary tumors with a similar latency period to mice with one or two wild-type ErbB4 alleles. Moreover, there was no difference in the histologies of tumors that developed, nor in the propensity to form lung metastases. Taken together these results suggest that ErbB4 is not a potent, highly penetrant tumor suppressor, nor is it a factor in Neu-mediated tumorigenesis in this model.

AB - The four members of the ErbB family of receptor tyrosine kinases are involved in development and tumorigenesis of the mammary gland. Whereas the epidermal growth factor receptor, ErbB2 and ErbB3 are positively associated with various cancers, clinical studies of ErbB4 in breast cancer are contradictory. Results from tissue culture analyses and some clinical studies suggested that ErbB4 is either a tumor suppressor or is a negative regulator of ErbB2-driven tumors. Neu-Cre-ErbB4flox/null mice in which ErbB4 was inactivated by Cre-lox-mediated recombination in the mammary gland developed MMTV-Neu-driven mammary tumors with a similar latency period to mice with one or two wild-type ErbB4 alleles. Moreover, there was no difference in the histologies of tumors that developed, nor in the propensity to form lung metastases. Taken together these results suggest that ErbB4 is not a potent, highly penetrant tumor suppressor, nor is it a factor in Neu-mediated tumorigenesis in this model.

KW - Breast cancer

KW - Carcinoma

KW - ErbB

KW - HER-4

KW - MMTV-Neu

UR - http://www.scopus.com/inward/record.url?scp=33748657615&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748657615&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1209574

DO - 10.1038/sj.onc.1209574

M3 - Article

C2 - 16652155

AN - SCOPUS:33748657615

VL - 25

SP - 5664

EP - 5672

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 41

ER -